Sign Research Foundation – Trademark Portfolio
Entity Type: 99
Sign Research Foundation holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SIGN RESEARCH FOUNDATION. The owner is based in Alexandria, DC.
1001 N. Fairfax Street
Alexandria, DC 22314
Showing of trademarks Trademarks
Trademark Classifications
Sign Research Foundation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Sign Research Foundation have?
Sign Research Foundation has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Sign Research Foundation file in?
Sign Research Foundation files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Sign Research Foundation's most well-known trademarks?
Sign Research Foundation's registered trademark portfolio includes well-known marks such as SIGN RESEARCH FOUNDATION. These are among 2 currently registered trademarks in the portfolio.
What is Sign Research Foundation's trademark registration success rate?
Sign Research Foundation has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.